These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 37705787)

  • 1. Nanoparticle-based delivery systems as emerging therapy in retinoblastoma: recent advances, challenges and prospects.
    Onugwu AL; Ugorji OL; Ufondu CA; Ihim SA; Echezona AC; Nwagwu CS; Onugwu SO; Uzondu SW; Agbo CP; Ogbonna JD; Attama AA
    Nanoscale Adv; 2023 Sep; 5(18):4628-4648. PubMed ID: 37705787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle-mediated gene therapy as a novel strategy for the treatment of retinoblastoma.
    Mandal M; Banerjee I; Mandal M
    Colloids Surf B Biointerfaces; 2022 Dec; 220():112899. PubMed ID: 36252537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-Functionalized Nanomaterials and Nanoparticles for Diagnosis and Treatment of Retinoblastoma.
    Arshad R; Barani M; Rahdar A; Sargazi S; Cucchiarini M; Pandey S; Kang M
    Biosensors (Basel); 2021 Mar; 11(4):. PubMed ID: 33810621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancements in the diagnosis, prognosis, and treatment of retinoblastoma.
    Rajput S; Malviya R; Uniyal P
    Can J Ophthalmol; 2024 Oct; 59(5):281-299. PubMed ID: 38369298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current therapy and recent advances in the management of retinoblastoma.
    Meel R; Radhakrishnan V; Bakhshi S
    Indian J Med Paediatr Oncol; 2012 Apr; 33(2):80-8. PubMed ID: 22988349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Options for Retinoblastoma.
    Mendoza PR; Grossniklaus HE
    Cancer Control; 2016 Apr; 23(2):99-109. PubMed ID: 27218786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in biomaterials for the treatment of retinoblastoma.
    Farhat W; Yeung V; Ross A; Kahale F; Boychev N; Kuang L; Chen L; Ciolino JB
    Biomater Sci; 2022 Sep; 10(19):5391-5429. PubMed ID: 35959730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of retinoblastoma: opportunities and challenges.
    Bhavsar D; Subramanian K; Sethuraman S; Krishnan UM
    Drug Deliv; 2016 Sep; 23(7):2488-2496. PubMed ID: 25758593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in active targeting of nanomaterials for anticancer drug delivery.
    Dutta B; Barick KC; Hassan PA
    Adv Colloid Interface Sci; 2021 Oct; 296():102509. PubMed ID: 34455211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy for retinoblastoma: a current topic.
    Finger PT; Czechonska G; Demirci H; Rausen A
    Drugs; 1999 Dec; 58(6):983-96. PubMed ID: 10651386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymer-Lipid Hybrid Nanoparticles: A Next-Generation Nanocarrier for Targeted Treatment of Solid Tumors.
    Rizwanullah M; Alam M; Harshita ; Mir SR; Rizvi MMA; Amin S
    Curr Pharm Des; 2020; 26(11):1206-1215. PubMed ID: 31951163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotechnology for Pediatric Retinoblastoma Therapy.
    Russo E; Spallarossa A; Tasso B; Villa C; Brullo C
    Pharmaceuticals (Basel); 2022 Aug; 15(9):. PubMed ID: 36145308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Retinoblastoma: What Is the Latest and What Is the Future.
    Schaiquevich P; Francis JH; Cancela MB; Carcaboso AM; Chantada GL; Abramson DH
    Front Oncol; 2022; 12():822330. PubMed ID: 35433448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of Nanoparticle-Based Radiosensitizers for Radiotherapy Applications.
    Boateng F; Ngwa W
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906108
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.